Medtronic PLC Form 4 insider transactions

Matthew R. Walter, SVP and Chief HR Officer of Medtronic plc, reports the disposition of 34 ordinary shares to cover tax obligations upon vesting of restricted stock units.

Chief Accounting Officer Denise L. Blomquist reports acquisition of restricted stock units and shares through dividend reinvestment, altering her beneficial ownership in Medtronic plc.

Kendall J. Powell, a director at Medtronic, reported the acquisition of shares through restricted stock units and the withholding of shares for tax obligations.

Director Elizabeth Nabel reports acquisition of shares via restricted stock units and disposition of shares for tax obligations.

Director Kevin E. Lofton reports acquisition of shares through restricted stock units and subsequent tax withholding.

Director Gregory P. Lewis reports acquisition of restricted stock units and shares, as well as shares withheld for tax obligations.

Randall J. Hogan, III, a director at Medtronic plc, reported the acquisition and disposal of ordinary shares, including the vesting of restricted stock units and shares withheld for tax payments.

Andrea Jo Goldsmith, a director at Medtronic plc, reported the acquisition of shares through a restricted stock unit award and the subsequent withholding of shares for tax obligations.

Director Lidia Fonseca reports acquisition and disposal of Medtronic plc ordinary shares.

Director Scott C. Donnelly reports acquisition and disposal of Medtronic plc ordinary shares.

Director Craig Arnold reports acquisition of restricted stock units and subsequent tax withholding.

Thierry Pieton, Medtronic's EVP & CFO, files an amended Form 4 to correct vesting and pricing information related to restricted stock units and stock options due to administrative errors in the original filing.

Michael Marinaro, EVP & President, Surgical OU at Medtronic plc, reported disposing of 575 ordinary shares to cover tax obligations arising from vesting restricted stock units.

Medtronic's EVP & CFO, Pieton Thierry, reports acquisition of restricted stock units and stock options, along with performance share units.

Matthew R. Walter, SVP and Chief HR Officer of Medtronic, reports the acquisition and disposal of ordinary shares and stock options on January 27, 2025.

Medtronic's EVP & President, Surgical OU, Michael Marinaro, exercised stock options and disposed of shares to cover tax obligations.

Medtronic's CEO, Geoffrey Martha, exercised stock options and sold a portion of the acquired shares on January 27, 2025.

Medtronic's Executive Vice President, Brett A. Wall, executed stock options and sold shares on January 24, 2025, according to a recent SEC filing.

Interim CFO Gary Louis Corona reports changes in beneficial ownership of Medtronic plc ordinary shares, including acquisition of restricted stock units and disposal of shares.

Medtronic EVP Brett A. Wall exercised stock options and sold shares on January 8, 2025, according to a recent SEC filing.

Medtronic's Executive Vice President and President of Neuroscience, Brett A. Wall, sold 645 shares to cover taxes upon vesting of restricted stock units.

Medtronic EVP & President Cardiovascular, Sean Salmon, sold 645 shares to cover taxes upon vesting of restricted stock units.

Medtronic's CEO, Geoffrey Martha, sold 4,417 shares to cover taxes upon the vesting of restricted stock units.

Medtronic's Executive Vice President and General Counsel, Ivan K. Fong, sold 532 ordinary shares to cover taxes related to vested restricted stock units.

Medtronic's Executive Vice President, Ivan K. Fong, sold 3,009 ordinary shares to cover taxes after restricted stock units vested, while also increasing his holdings through dividend reinvestment.

Medtronic's Chief Accounting Officer, Jennifer M. Kirk, sold shares to cover taxes upon the vesting of restricted stock units.

Medtronic's Interim CFO, Gary Louis Corona, sold 662 shares to cover taxes after restricted stock units vested, while also increasing his holdings through dividend reinvestment and the employee stock ownership plan.

Michael Marinaro, EVP & President, Surgical OU at Medtronic, reported disposing of 2,045 ordinary shares to cover tax obligations related to vesting restricted stock units.

Interim CFO of Medtronic, Gary Louis Corona, reports acquiring and disposing of ordinary shares and holding restricted stock units.

EVP Brett A. Wall reports acquisition and disposal of Medtronic plc ordinary shares related to performance share unit vesting and tax withholding.